B-cell-biased lymphoid progenitors (BLPs) and Pre-pro B cells lie at a critical juncture between B cell specification and commitment. However, both of these populations are heterogenous, which hampers investigation into the molecular changes that occur as lymphoid progenitors commit to the B cell lineage. Here, we demonstrate that there are PDCA-1 
Introduction
The generation of B lineage lymphocytes from multipotent hematopoietic progenitors (MPP) is an ordered process orchestrated by genetic networks that initiate activation of the lymphoid lineage developmental program followed by specification and commitment to the B cell fate. At present, at least eight progenitor stages have been characterized between MPP and naïve B cells [1] [2] [3] [4] . The various progenitor stages are distinguished by differential expression of combinations of cell surface markers, and regulated expression of genes that drive B cell development. However, it has become increasingly evident that some commonly used cell surface marker combinations do not adequately discriminate B cell precursors within transitional subsets from other lymphoid cells at various stages in their developmental programs. In some cases, this limitation has impeded the precise identification of developmental stage specific roles of regulatory factors in B lineage specification and commitment.
In particular, the developmental stages in which a common lymphoid progenitor (CLP) differentiates into a committed pro-B cell that has lost all other lineage potential is unclear. As B lineage precursors progress from CLPs to Pre-pro B cells to pro-B cells, the inability to purify B cell progenitors based on cell surface markers alone has led to the use of integrated reporters under the control of regulatory elements turned on during B cell differentiation including Rag1-GFP [5, 6] and l5-hCD25 [7] to purify the earliest specified and committed B cell progenitors [8, 9] . The Rag1-GFP + CLP population is heterogenous as well [8] . Singlecell PCR analysis revealed that while all the cells expressed EBF1, only half expressed either Pax5 or Pou2af1 [8] . Recently, Ly6D was discovered as a marker that could distinguish between cells with multi-lineage lymphoid potential and those specified to the B cell lineage within the CLP population [3] . Ly6D
2 CLPs termed ALPs (all-lymphoid progenitors) give rise to T, B and NK cells, while Ly6D
+ CLPs termed BLPs (B-cell biased lymphoid progenitors) give rise almost exclusively to B cells but very few T cells or NK cells in vivo [3] . While Ly6D can differentiate ALPs from BLPs within CLPs, BLPs are not a homogenous population. Differentiation of BLPs using in vitro culture resulted in the production of CD11c
+ DCs in addition to CD19 + B cells [3] . Therefore, additional markers are needed to separate each stage of B cell progenitors within the CLP and Pre-pro B populations. Here, we demonstrate that PDCA-1 + SiglecH + plasmacytoid dendritic cells (pDCs) co-purify with BLPs and Pre-pro B cells. Once the pDC are removed using PDCA-1, the resulting PDCA-1 2 BLPs and Pre-pro B cells populations express high levels of a Rag1-GFP reporter, indicating that these cells have initiated the B cell program. Once PDCA-1 + pDC are removed from the BLP and Pre-pro B populations, it revealed that the block in B cell Figure 1 . Identification of a plasmacytoid dendritic cell subset within the common lymphoid progenitor population. (A) Flow cytometry analysis was used to examine CLP populations from Rag1-GFP mice. Cells were first gated according to expression of IL-7Ra and low/ negative of expression of lineage markers using a lineage cocktail containing antibodies against CD3e, TCRb, TCRcd, B220, CD19, Ly6C, Ter119, CD11c, CD11b, Gr-1, NK1.1 and CD8a (left panel figure 1 (A). (C) Quantitative PCR was performed on ALPs, BLPs and PDCA-1 + CLPs (color coded as in the gating shown in figure 1(A) ). Each population was independently isolated by FACS sorting using the gating strategy in (A). Relative expression of EBF1, Pax5, Runx2 and Pacsin1 is shown. Data shown is the average of 4 independently sorted samples from 4 WT mice, and error bars reflect the standard error of the mean. Data was normalized to the expression of each gene in one of the four WT BLP samples. Significance was quantified using unpaired two-tailed t test (GraphPad Prism). knockout (KO) mice were examined for ALPs and BLPs using the gating strategy described in Figure 1A , except that Ly6C was analyzed separately from lineage (using a lineage cocktail as in Figure 1A except lacking Ly6C). Data shown is representative of 4 WT and 4 FL KO mice from 4 independent experiments. (B) WT and IL-7Ra KO mice were examined for ALPs and BLPs using the gating strategy as in Figure 2A, 
Results
Plasmacytoid dendritic cells (pDCs) share many cell surface markers with B lymphoid progenitors, and have traditionally been excluded from lineage cocktails using Ly6C and/or CD11c [3, 10] . However, as dendritic cells are very heterogenous, with distinct populations expressing low levels of CD11c [11] or Ly6C [12] , it was possible that these two markers alone would be insufficient for exclusion of dendritic cells in the lineage cocktail used to examine lymphoid progenitors. In particular, plasmacytoid dendritic cells (pDCs) express high levels of Ly6D, the marker used to define BLPs within the CLP gate [3] . PDCA-1 is found on the surface of pDCs [13] , and was used to examine whether pDCs remained after lineage exclusion for examination of CLPs. Our gating strategy for CLPs is shown in figure 1A , gating first on lin low (lineage cocktail containing antibodies against CD3e, TCRb, TCRcd, B220, CD19, Ly6C, Ter119, CD11c, CD11b, Gr-1, NK1.1 and CD8a), IL-7Ra + , c-Kit low and Flt3 high as was performed in [3] . This CLP population was then examined for Ly6D expression to differentiate ALPs from BLPs [3] , and for PDCA-1 expression. PDCA-1 positive cells comprised a substantial proportion of Ly6D + BLPs, but were not found in the earlier Ly6D 2 ALPs. The CLP pool is heterogenous, and transgenic reporters such as Rag1-GFP and l5 are often used to identify subpopulations destined to become B cells [8] . We hypothesized that the heterogeneity of Rag1-GFP reporter expression within the BLP population is due to contaminating PDCA-1 + cells. As shown in figure 1A , PDCA-1 2 Ly6D + BLPs expressed high levels of the Rag1-GFP reporter while few PDCA-1 + CLPs were Rag1-GFP positive (even lower than in Ly6D 2 ALPs). We examined expression of Flt3, c-kit and IL-7Ra in each of these CLP populations, however due to considerable overlap between the histograms, these markers cannot be used to distinguish PDCA-1 + CLPs from PDCA-1 2 BLPs. Therefore, the lack of PDCA-1 expression can be used to distinguish a subpopulation of Ly6D + BLPs that express high levels of Rag1-GFP reporter and are specified but not yet committed to the B cell lineage [3] .
To confirm the identity of these PDCA-1 + CLPs, we examined additional cell surface markers as well as expression of genes characteristic of the B cell and pDC lineages by Q-PCR. The PDCA-1 + CLPs expressed Siglec H, which is primarily expressed on pDCs and not on other hematopoietic lineages [14] , and did not express DX5 (figure 1B). To confirm that these PDCA-1+ CLPs were pDCs, we examined the expression of Runx2 [15] and Pacsin1 [16] . Previous analysis by the Immgen Consortium [17] , demonstrated that Pacsin1 and Runx2 are expressed by pDCs but not any conventional DC lineage. In addition, analysis of the Immgen database showed that Pacsin1 is not expressed by any B cell lineage and that Runx2 is expressed in B cell progenitors albeit at a considerably lower level than pDCs. Thus, differential expression of Runx2 and Pacsin1, in comparison to the B lineage genes EBF1 [18] and Pax5 [18] which are required for B cell specification and commitment, could differentiate B lineage progenitors from pDCs. As shown in figure 1B, expression of these genes was low in ALPs, and only EBF1 and Pax5 (but not Runx2 or Pacsin1) were upregulated in BLPs. The PDCA-1 + CLPs expressed high levels of Runx2 and Pacsin1, but not EBF1 or Pax5, indicating that they were pDCs. Although CD11c and Ly6C were included in the lineage cocktail, pDC populations have been identified with low levels of both CD11c [11] or lack of Ly6C [12] , indicating that these markers may not be sufficient to eliminate pDCs in a lineage cocktail. Here, we show that PDCA-1 is an effective marker to discriminate pDCs from BLPs within the CLP population.
The presence of PDCA-1 + pDCs in the the Ly6D + CLP population could mask a defect in BLPs in genetically modified mice. In particular, there are conflicting results when the block in B cell development occurs in IL-7Ra knockout (KO) mice. Previous work by others identified the block at the CLP stage [19] , the Pre-pro B stage [20] , or the Pro-B (Fraction B) cell stage [21, 22] . Due to the overlap in cell surface markers between CLPs and PDCA-1+ SiglecH+ pDCs (figure 1), the presence of pDCs could be misinterpreted as CLPs. Therefore, we included PDCA-1 in our analysis of the BLP population in IL-7Ra KO mice. We also included Ly6C separately from the lineage markers to confirm that the PDCA-1 + CLPs were Ly6C low/negative. This analysis demonstrates that the majority of Ly6D + CLPs in IL-7Ra KO ( Figure 2B ) are PDCA-1 + pDCs and not BLPs, indicating that the block in lymphocyte development in IL-7Ra KO is at the transition between ALPs and BLPs. Similar results were obtained in analysis of Flt3-ligand (FL) KO mice that are impaired in their ability to generate B cell progenitors [23, 24] . We also analyzed absolute numbers of (PDCA-1
2 ) BLPs as well as total Ly6D + CLPs (which includes both PDCA-1 2 BLPs and PDCA-1 + pDCs).
Analysis of total Ly6D
+ CLPs revealed no differences between WT and IL-7Ra KO mice. However, when PDCA-1 + pDCs were excluded, the number of BLPs was significantly lower in IL-7Ra KO mice ( Figure 2C ). Thus, removal of PDCA-1 + pDC from the BLP gate revealed a defect in B cell development in IL-7Ra KO mice and FL KO mice at the ALP stage.
Similarly, pDCs are also found within the heterogenous B220 +
CD19
2 Pre-pro B population [25] . Pre-pro B cells have been shown to express both AA4.1/CD93 [26, 27] and Ly6D [3] . As shown in figure 3A, there were four major populations within the B220 + CD19 2 gate. Of the cells that express both AA4.1 and Ly6D, a substantial percentage were PDCA-1 + (blue gate), and a smaller percentage were negative and thus potentially represented Pre-pro B cells (red gate), the immediate precursor to committed CD19 + B cell progenitors. As Rag1 gene expression precedes commitment to the B cell lineage [6] , expression of a Rag1-GFP transgenic reporter [5] was examined in each of the four populations in the B220 +
2 gate. High levels of Rag1-GFP expression was only found within the AA4.1 
Ly6D
+ PDCA-1 + populations, additional markers were examined ( Figure 3C) 
CD43
hi . The expression of CD4, Gr-1 and low level of CD11b expression is consistent with this population being pDCs [11, 28] . In addition, the PDCA-1 + cells in the B220
+ CD19 2 population also expressed Siglec-H, but not DX5 or NK1.1, demonstrating their identity as pDCs. We Figure 3A , and cultured on OP9 stromal cells with exogenous IL-7, Flt3-ligand and SCF. After 4 days, the cultures were analyzed by flow cytometry and the number of CD19
+ cells produced compared to the number of progenitors plated were compared. As shown in figure 3C , the AA4. [29, 30] . However, based on our work in CLPs above, neither Ly6C nor CD11c may be sufficient to remove pDCs from Pre-pro B cells. This was analyzed in figure 4 , to determine whether first gating for Ly6C [21] and Flt3 ligand KO mice [24] . These mice share deficiencies in CLPs and B cell precursors, but have been reported to exhibit normal numbers of Pre-pro B cells [31, 32] . However, as PDCA-1 + SiglecH + pDCs contaminate the Pre-pro B population, a defect in Pre-pro B cells may have been masked by pDCs. As shown in Figure 5 , severe reductions in Pre-pro B cells, both in frequency and absolute numbers, were found in mice deficient for IL-7Ra and Flt3 ligand, using our modified gating scheme excluding PDCA-1 + pDCs, consistent with expectations based on defects in the CLP and subsequent pro-B cell populations. In particular, we compared the absolute number of Pre-pro B cells in these mice, either using AA4.1
+

Ly6D
+ to define Pre-pro B cells (right panel) or after exclusion of PDCA-1 + pDCs (left panel). Without exclusion of PDCA-1 + pDCs, the number of Pre-pro B cells in IL-7Ra-deficient mice was similar to WT. However, after exclusion of PDCA-1 + pDCs, a nearly complete deficiency in Pre-pro B cells in IL-7Ra-deficient mice was revealed. Therefore, PDCA-1 is an important marker to exclude pDCs from both the Pre-pro B and BLP gates.
Discussion
Here, we demonstrate that PDCA-1 + SiglecH + plasmacytoid dendritic cells (pDCs) co-purify with BLPs and Pre-pro B cells. Removal of PDCA-1 + pDCs separates B cell progenitors that express high levels of Rag1-GFP reporter from Rag1-GFP low/neg pDCs within the BLP and Pre-pro B populations. In general, there are many similarities in expression of cell surface markers between pDC and B cell progenitors. They both express IL-7Ra, Flt3, c-kit, as well as markers traditionally identified as belonging exclusively to the B cell lineage including AA4.1, B220 and Ly6D. Thus, it is perhaps not surprising that pDCs copurify with CLPs and Pre-pro B cells. Given the similarity in cell surface markers, B cell progenitors may also copurify with pDCs. Therefore, PDCA-1 should be used in conjunction with Ly6C and CD11c to remove pDCs from B cell progenitor analysis. The presence of pDCs within the BLP and AA4.1
+
Ly6D
+ Pre-pro B populations would confound analysis of differential gene expression between WT and genetically altered mice if these cells are not accounted for in the cell purification scheme, as they also express several genes characteristically associated with B cell lineage commitment and specification including Pax5, EBF and CD79a/mb1 [11] . For example, we demonstrate that BLPs and Pre-pro B cells are absent in IL-7Ra knockout mice, but PDCA-1
+ cells in the Pre-pro B gate and PDCA-1 + pDCs in the CLP gate are present. Therefore, with prior gating strategies, PDCA-1 + pDCs would be mistaken for B cell progenitors cells in these mice, and would express a genetic signature that contained elements usually associated with the B cell lineage. By gating out PDCA-1
+ pDCs, we demonstrate that the block in B cell development in IL-7Ra KO and FL KO mice is at the ALP stage.
Recently, two groups used different 12 parameter flow cytometry profiles to identify Pre-pro B cells [3, 4] , however neither groups specifically excluded pDCs. Here, we show that B220 +
CD19
2 B cell precursors enriched for Pre-pro B cells can be divided into 4 populations using the markers AA4.1, Ly6D and PDCA-1, only one of which (AA4.1 + Ly6D + PDCA-1 2 ) has uniformly high levels of Rag1-GFP reporter expression. Thus, Rag1-GFP + Pre-pro B cells can be identified using only 5 markers. In our analysis, Pre-pro B cells express intermediate levels of CD43, consistent with previous results ( Figure 1D, [4] ). Often, the B220
high population is fractionated into CD19 2 pre-pro B and CD19
+ pro-B cell populations [33, 34] . However, our analyses show that these B220 + CD43 high CD19 2 cells are PDCA-1 + pDCs and not Pre-pro B cells.
The discovery of pDCs within the BLP population may explain the conflicting data with regards to their origin [35] . pDCs have been shown to arise from lymphoid-biased multipotent progenitors figure 3A ) and B220 + CD19 2 AA4.1
+ cells (blue gate in figure 3A ) was examined by sorting each population onto OP9 stromal cells in media containing IL-7, Stem cell factor (SCF) and Flt3 ligand. After 4 days, cells were stained with CD19 and the total number of CD19 + cells generated compared to the number of input sorted cells per well was calculated (frequency of generation of CD19 + cells). The frequency was calcuated from 7 independent wells per sample from 3 independent sorts. Statistical analysis was performed using an unpaired two-tailed t test (GraphPad Prism). doi:10.1371/journal.pone.0078408.g003
PDCA-1 Separates pDC from B Lineage Precursors PLOS ONE | www.plosone.org (LMPPs), common myeloid progenitors (CMPs), as well as CLPs [36] [37] [38] [39] . However, our data demonstrates that PDCA-1 + pDCs persist in the CLP gate, even after utilizing a lineage cocktail that contains Ly6C, CD11c, CD11b and Gr-1. Without the use of PDCA-1, pDCs co-purify with CLPs and could therefore be expanded upon in vitro culture of CLPs, and thus confuse the analysis and interpretation regarding the origin of pDCs.
Here, we also show there is heterogeneity in the pDC population as well. We identified PDCA-1 + SiglecH + pDC which are not removed from the lineage low population using Ly6C and CD11c that co-purify with CLPs and Pre-pro B cells. Where these pDCs fall within the continuum of pDC development is unclear. Onai et al [36] recently found a unique progenitor population (Lin-c-kit int/lo Flt3 + M-CSFR 2 ) that produce pDC at high frequen- cy, but lack expression of PDCA-1 or Siglec H. Differentiation of these pDC precursors in culture produces cells with high levels of PDCA-1 and Siglec H expression [36] . The pDCs that copurify with CLP and Pre-pro B cells express both PDCA-1 and Siglec H, and therefore would be downstream of these newly identified pDC precursors. Whether these cells represent a developmental intermediate during pDC development and differentiation, or a unique lineage, is currently under investigation.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The work was performed with the approval of the Mayo Clinic Institutional Animal Care and Use Committee (OLAW Assurance number A3291-01).
Mice
Flt3 ligand knockout mice [24] were received from Taconic Farms and IL-7Ra knockout mice [21] were received from Jackson Laboratories. Rag1-GFP mice were generated and provided by Dr. Nobuo Sakaguchi [5] . WT mice used were C57BL/6 from either Taconic Farms or Jackson Laboratories. All animals were analyzed between 8 and 20 weeks of age.
Flow cytometry
Antibodies were from eBioscience, Biolegend or Becton Dickinson. All samples were gated on size, and doublet excluded during analysis using FSC-H/FSC-W as well as SSC-H/SSC-W. The lineage depletion cocktail for analysis of CLPs contained twelve antibodies to exclude differentiated hematopoietic populations: CD3e, TCRb, TCRcd, B220, CD19, Ly6C, Ter119, CD11c, CD11b, Gr-1, NK1.1 and CD8a, all conjugated to APC. Other antibodies used in analysis of CLPs included Flt3-PE, IL7Ra-biotin/streptaviding PE-Cy7, c-kit-APC-Cy7, and PDCA-1 efluor450. For experiments analyzing CLPs with Ly6C, an APC lineage cocktail as above without Ly6C was used and Ly6C-PerCP-Cy5.5 was used. For pre-pro B cells in wild-type mice, 10 million bone marrow cells were stained with the following antibodies: Ly6D-FITC (BD Biosciences); CD93/AA4.1-PE (eBioscience); PDCA-1 PerCP-efluor 710 (eBioscience); CD19-PECy7 (eBioscience) and B220-APC-Cy7 (Biolegend). For experiments in Pre-pro B cells analyzing Rag1-GFP expression, Ly6D-efluor450 was used. Analysis was performed on a Canto or LSRII flow cytometer (Becton Dickinson), and analyzed using FlowJo software (TreeStar), with 0.5-1.0 million events collected per sample. In all experiments except where efluor450 was used, DAPI was used to exclude dead cells.
Quantitative PCR
ALPs, BLPs and PDCA1+ CLPs from 4 WT mice (using the gating strategy described in Figure 1 ) were sorted on an Aria flow cytometer (Becton Dickinson). RNA was generated using a RNeasy micro kit (Qiagen), and amplified cDNA generated using Ovation PicoSL WTA kit v2 (NuGen), both as per manufacturer's instructions. Taqman probes (Applied Biosystems) for EBF1, Pax5, Runx2, Pacsin1 and HPRT were used. An ABI StepOne Plus System (Applied Biosystems) was used and expression relative to HPRT was calculated with the 2-DDCT method [40] .
B cell differentiation cultures
Single cell bone marrow suspensions were generated from WT mice. B lineage precursors wre enriched by magnetic depletion of Ter119 Figure 3A ) and B220 +
CD19
2 AA4.1 + Ly6D + PDCA-1 + cells (blue gate, as shown in Figure 3A ) were sorted using a FACS-Aria (BD Biosciences). The sorted cells were plated on OP9 stromal cells in IMDM media with 10% FBS, L-Glutamine, b-mercaptoethanol, 10 ng/ml human IL-7, 10 ng/ml Stem Cell Factor and 10 ng/ml human Flt3-ligand. All cytokines were from Peprotech. After 4 days in culture, the cells were harvested, and analyzed for expression of CD19.
